These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2956609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
    Rocco S, Opocher G, Carpenè G, Mantero F.
    Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension.
    Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Fukui K, Sugimoto T, Yamakado M, Tagawa H, Miyata A, Kangawa K.
    Circulation; 1988 Dec; 78(6):1401-10. PubMed ID: 2847885
    [Abstract] [Full Text] [Related]

  • 8. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J, Abraham WT, Dürr JA, Schrier RW.
    Am J Nephrol; 1991 Dec; 11(6):441-6. PubMed ID: 1840232
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
    Sergev O, Rácz K, Varga I, Kiss R, Fütö L, Gutkowska J, Gláz E.
    Clin Exp Hypertens A; 1991 Dec; 13(3):409-23. PubMed ID: 1832596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma atrial natriuretic peptide (ANP) in primary aldosteronism.
    Chen JH, Tsai JH, Lai YH, Hwang SJ.
    Taiwan Yi Xue Hui Za Zhi; 1988 Sep; 87(9):851-6. PubMed ID: 2975697
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alpha-h-ANP injection in normals, low renin hypertension and primary aldosteronism.
    Mantero F, Rocco S, Pertile F, Carpené G, Fallo F, Menegus A.
    J Steroid Biochem; 1987 Sep; 27(4-6):935-40. PubMed ID: 2961943
    [Abstract] [Full Text] [Related]

  • 20. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter JD.
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.